- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MEDIFAST INC (MED)
MEDIFAST INC stock price live, this page displays NYSE MED stock exchange data. View the MED premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the MEDIFAST INC real time stock price chart below.
What Is the MEDIFAST INC Stock Price Today?
The MEDIFAST INC stock price today is 11.79.
What Is the Stock Symbol for MEDIFAST INC?
The stock symbol for MEDIFAST INC is "MED."
What Stock Exchange Does MEDIFAST INC Trade On?
MEDIFAST INC is listed and trades on the NYSE stock exchange.
Is MEDIFAST INC a Good Stock to Buy?
Determining whether MEDIFAST INC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MED quote. (ISIN: US58470H1014)
What Is the MEDIFAST INC Stock Price Today?
The MEDIFAST INC stock price today is 11.79.
What Is the Stock Symbol for MEDIFAST INC?
The stock symbol for MEDIFAST INC is "MED."
What Stock Exchange Does MEDIFAST INC Trade On?
MEDIFAST INC is listed and trades on the NYSE stock exchange.
Is MEDIFAST INC a Good Stock to Buy?
Determining whether MEDIFAST INC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MED quote. (ISIN: US58470H1014)
11.79
-0.49(-3.99%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.70
12.47
52 wk Range
9.22
14.67
MED is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.7012.47
52 wk Range
9.2214.67
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MED Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
12.00
Upside
+1.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 12.00
(+1.78% Upside)
MEDIFAST INC Earnings Call Summary for Q2/2026
- Medifast posted Q2 loss of $0.28/share on $76.4M revenue, beating estimates of $0.43 loss and $74.7M; shares surged 13.96% after-hours to $11.10.
- Revenue fell 27.6% YoY amid 48.7% drop in active coaches to 11,700, but productivity rose 41% YoY to $6,529 per coach, highest since Q2 2022.
- Company launched Trilivy brand replacing OPTAVIA, targeting broader metabolic health market including GLP-1 drug users; transition received positively.
- Management maintained FY2026 guidance of $270M-$300M revenue, expects Q4 return to profitability via Catalyst cost-cutting program and productivity gains.
- Q3 outlook calls for $60M-$80M revenue and $0.15-$0.65 loss/share; firm holds $169.8M cash with zero debt despite ongoing market headwinds.
Last Updated: 08/04/2026, 05:14 AM
Read Full TranscriptEarnings
Latest Release
Aug 03, 2026
EPS / Forecast
-0.28 / -0.43
Revenue / Forecast
76.4M / 74.7M
Compare MED to Peers and Sector
Metrics to compare | MED | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipMEDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.0x | −5.0x | 11.7x | |
PEG Ratio | 0.01 | 0.01 | 0.03 | |
Price/Book | 0.6x | 1.7x | 1.5x | |
Price / LTM Sales | 0.4x | 0.4x | 0.9x | |
Upside (Analyst Target) | −2.1% | 33.3% | 24.3% | |
Fair Value Upside | Unlock | 18.2% | 13.9% | Unlock |
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body’s metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients’ long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body’s metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the MEDIFAST (MED) Stock Price Today?
The MEDIFAST stock price today is 11.79 USD.
What Stock Exchange Does MEDIFAST Trade On?
MEDIFAST is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for MEDIFAST?
The stock symbol for MEDIFAST is "MED."
What Is the MEDIFAST Market Cap?
As of today, MEDIFAST market cap is 120.96M USD.
What Is MEDIFAST's Earnings Per Share (TTM)?
The MEDIFAST EPS (TTM) is -2.32.
When Is the Next MEDIFAST Earnings Date?
MEDIFAST will release its next earnings report on Nov 09, 2026.
From a Technical Analysis Perspective, Is MED a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has MEDIFAST Stock Split?
MEDIFAST has split 0 times.
How Many Employees Does MEDIFAST Have?
MEDIFAST has 380 employees.
What is the current trading status of MEDIFAST (MED)?
As of Aug 06, 2026, MEDIFAST (MED) is trading at a price of 11.79 USD, with a previous close of 12.28 USD. The stock has fluctuated within a day range of 11.70 USD to 12.47 USD, while its 52-week range spans from 9.22 USD to 14.67 USD.
What Is MEDIFAST (MED) Price Target According to Analysts?
The average 12-month price target for MEDIFAST is 12.00 USD, with a high estimate of 12 USD and a low estimate of 12 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +1.78% Upside potential.
What Is the MED After Hours Price?
MED's last after hours stock price is 12.24 USD, the stock has decreased by -0.04, or -0.33%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.